Ana Bobinac
Overview
Explore the profile of Ana Bobinac including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van de Wetering L, van Exel J, Bobinac A, Brouwer W
Pharmacoeconomics
. 2015 Aug;
33(12):1289-300.
PMID: 26232199
Background: To judge whether an intervention offers value for money, the incremental costs per gained quality-adjusted life-year (QALY) need to be compared with some relevant threshold, which ideally reflects the...
12.
Bobinac A, van Exel J, Rutten F, Brouwer W
Pharmacoeconomics
. 2013 Dec;
32(1):75-86.
PMID: 24293198
Background: There is an increased interest in the monetary value of a quality-adjusted life-year (QALY). Past studies commonly derived willingness to pay (WTP) for certain future QALY gains. However, obtaining...
13.
Bobinac A, van Exel N, Rutten F, Brouwer W
Value Health
. 2012 Dec;
15(8):1119-26.
PMID: 23244815
Background: A commonly held view of the decision rule in economic evaluations in health care is that the final incremental cost-effectiveness ratio needs to be judged against some threshold, which...
14.
Bobinac A, van Exel N, Rutten F, Brouwer W
Health Econ
. 2012 Oct;
22(10):1272-81.
PMID: 23080321
Interpreting the outcomes of cost utility analyses requires an appropriately defined threshold for costs per quality-adjusted life year (QALY). A common view is that the threshold should represent the (consumption)...
15.
Bobinac A, van Exel N, Rutten F, Brouwer W
J Health Econ
. 2011 Oct;
31(1):158-68.
PMID: 22018622
Estimates of WTP per QALY can be taken as an indication of the monetary value of health gains, which may carry information regarding the appropriate height of the cost-effectiveness threshold....
16.
Bobinac A, van Exel N, Rutten F, Brouwer W
Value Health
. 2010 Sep;
13(8):1046-55.
PMID: 20825620
Objective: The aim of this study was to elicit the individual willingness to pay (WTP) for a quality-adjusted life-year (QALY). Methods: In a Web-based questionnaire containing contingent valuation exercises, respondents...
17.
Bobinac A, van Exel N, Rutten F, Brouwer W
Med Decis Making
. 2010 Jul;
31(2):292-8.
PMID: 20671212
Background: Changes in the health of patients may affect the health of so-called "significant others" in 2 distinct ways. First, an individual may provide informal care to the patient and...
18.
Bobinac A, van Exel N, Rutten F, Brouwer W
J Health Econ
. 2010 Jun;
29(4):549-56.
PMID: 20579755
Besides patients' health and well-being, healthcare interventions may affect the well-being of significant others. Such 'spill over effects' in significant others may be distinguished in two distinct effects: (i) the...
19.
van Exel J, Bobinac A, Koopmanschap M, Brouwer W
Expert Rev Pharmacoecon Outcomes Res
. 2010 Jun;
8(6):557-61.
PMID: 20528366
The healthcare sector depends heavily on the informal care provided by families and friends of those who are ill. Informal caregivers may experience significant burden as well as health and...
20.
Bobinac A, Brouwer W, van Exel J
Health Econ
. 2009 Dec;
20(1):111-9.
PMID: 20029933
We tested the influence of the growth in life expectancy over time on social time preferences for health. Growing life expectancy of future generations should raise social discount rates for...